O

Ovid Therapeutics
D

OVID

1.11000
USD
0.02
(1.37%)
Market Closed
Volume
532
EPS
-0
Div Yield
-
P/E
-2
Market Cap
78,820,951
OverviewSignalsIdeasNews
Related Instruments
    B
    BGNE
    -4.220
    (-2.18%)
    189.320 USD
    B
    BLCM
    -0.01620
    (-4.09%)
    0.36000 USD
    K
    KURA
    -0.560
    (-3.40%)
    15.920 USD
    L
    LPCN
    -0.32000
    (-6.14%)
    4.89000 USD
    O
    OVID
    -0.08500
    (-7.42%)
    1.06000 USD
    P
    PLX
    -0.02000
    (-1.42%)
    1.39000 USD
    R
    RCEL
    -0.640
    (-5.08%)
    11.960 USD
    S
    SLDB
    -0.45000
    (-8.46%)
    4.87000 USD
    S
    SRRK
    -1.030
    (-3.74%)
    26.500 USD
    More
News

Title: Ovid Therapeutics

Sector: Healthcare
Industry: Biotechnology
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with apotential in-class mechanism of action.